Lexaria Bioscience Corp (LEXX) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from May 31 2026 to May 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Lexaria Bioscience Corp   (NASDAQ: LEXX)


Lexaria Bioscience's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Lexaria Bioscience's ROI in the third quarter of 2026?
Lexaria Bioscience Corp recorded a cumulative net loss of $-8 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -175.37%.

Within the Healthcare sector 3 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 89 to 4096.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (May 31 2026)
III. Quarter		 (Feb 28 2026)
II. Quarter		 (Nov 30 2025)
I. Quarter		 (Aug 31 2025)
IV. Quarter		 (May 31 2025)
III. Quarter
Y / Y Investment Change TTM -36.25 % -43.57 % -40.39 % -9.08 % 35.3 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 4 6 5 3 5
Return On Investment (TTM) -175.37 % -210.15 % -230.54 % -206.02 % -164.65 %
LEXX's Overall Ranking # 4096 # 89 # 96 # 3612 # 3726
Seq. Investment Change TTM -2.75 % -3.14 % -18.96 % -16.5 % -13.91 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -8 -10 -11 -12 -11

LEXX Company Profile >> Back to LEXX Roi Comparisons >> See Annual LEXX Return On Investment



Return On Investment LEXX's Ranking
Within: No.
Industry # 2
Sector # 4
Overall # 4096

Return On Investment Statistics
High Average Low
-10.14 %
-942.29 %
-30938.3 %
(Nov 30 2021)   (Aug 31 2016)







Financial Statements
Lexaria Bioscience's III. Quarter Investments $ 4 Millions LEXX's Balance sheet
Lexaria Bioscience's III. Quarter Income $ -2 Millions Quarterly LEXX's Income Statement
LEXX's Income by Division See LEXX's Income by Division


LEXX Annual Return On Investment (Aug 31 2025)
2025		 (Aug 31 2024)
2024		 (Aug 31 2023)
2023		 (Aug 31 2022)
2022		 (Aug 31 2021)
2021
Total Investments in Millions 3 7 2 7 13
Y / Y Investment Growth -64.26 % 214.4 % -68.34 % -43.34 % 422.73 %
Net Income in Millions -12 -6 -7 -7 -4
Y / Y Net Income Growth - - - - -
Annual Return On Investment -457.65 % -79.77 % -289.83 % -97.8 % -29.96 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LEXX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LEXX's Competitors
Subscribers only: Roi for Lexaria Bioscience's Suppliers
Subscribers only: Return On Investment for LEXX's Customers

Other Ratios
LEXX's Roa LEXX's Inventory Turnover Ratio LEXX's Growth Rates LEXX's Dividend Statistics
LEXX's Profitability Ratios LEXX's Asset Turnover Ratio LEXX's Dividend Growth
LEXX's Roe LEXX's Valuation Ratios LEXX's Financial Strength Ratios LEXX's Dividend Payout Ratio



Companies with similar Return On Investment at May 31 2026, within Healthcare Sector ROI

Date modified: 2026-08-03T18:30:59+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.